Company Filing History:
Years Active: 2005
Title: The Innovations of Nicholas Kindor
Introduction
Nicholas Kindor is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate chemokine receptor activity. His work is essential for advancing therapies for various diseases related to chemokine receptors.
Latest Patents
Nicholas Kindor holds a patent for "Substituted piperidine compounds useful as modulators of chemokine receptor activity." This invention provides compounds of a specific formula, detailing the processes for their preparation, pharmaceutical compositions containing them, and their therapeutic uses. The focus of this patent is on treating diseases and conditions related to chemokine receptor activity.
Career Highlights
Nicholas is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to innovative research and development in the pharmaceutical industry. His expertise in chemistry and pharmacology has been instrumental in his career.
Collaborations
Nicholas has collaborated with esteemed colleagues such as Stephen Thom and Andrew Baxter. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Nicholas Kindor's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions through patents and collaborations continue to influence the development of new therapies for chemokine receptor-related diseases.